Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Losartan + Hydrochlorothiazide
- Therapeutic area
- Cardiovascular
- Drug class
- Angiotensin receptor blockers
- ATC
- C09CA
- Strength
- 50 mg + 12.5 mg
- Dosage form
- Tablet
- Pack
- 2x10's
- Registration no.
- 060541
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-26 02:57
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (2x10's). Current price PKR 464.43, effective 13 May 2026.
Cite this price history
MedInfoBase. I-Sartan Plus 50 mg + 12.5 mg, 2x10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/i-sartan-plus-50-mg-12-5-mg-060541-2x10s-irza-pharma-pvt-ltd/ (accessed 26 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 464.43 | 2026-05-13 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 060541Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
